File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Neurological soft signs in schizophrenia: A meta-analysis

TitleNeurological soft signs in schizophrenia: A meta-analysis
Authors
KeywordsMeta-analysis
Neurological soft signs
Schizophrenia
Issue Date2010
Citation
Schizophrenia Bulletin, 2010, v. 36, n. 6, p. 1089-1104 How to Cite?
AbstractBackground: Neurological soft signs (NSS) are hypothesized as candidate endophenotypes for schizophrenia, but their prevalence and relations with clinical and demographic data are unknown. The authors undertook a quantification (meta-analysis) of the published literature on NSS in patients with schizophrenia and healthy controls. A systematic search was conducted for published articles reporting NSS and related data using standard measures in schizophrenia and healthy comparison groups. Method: A systematic search was conducted for published articles reporting data on the prevalence of NSS in schizophrenia using standard clinical rating scales and healthy comparison groups. Meta-analyses were performed using the Comprehensive Meta-analysis software package. Effect sizes (Cohen d) indexing the difference between schizophrenic patients and the healthy controls were calculated on the basis of reported statistics. Potential moderator variables evaluated included age of patient samples, level of education, sample sex proportions, medication doses, and negative and positive symptoms. Results: A total of 33 articlesmet inclusion criteria for the meta-analysis. A large and reliable group difference (Cohen d) indicated that, on average, a majority of patients (73%) perform outside the range of healthy subjects on aggregate NSS measures. Cognitive performance and positive and negative symptoms share 2%-10%of their variance with NSS. Conclusions: NSS occur in a majority of the schizophrenia patient population and are largely distinct from symptomatic and cognitive features of the illness. © The Author 2009. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved.
Persistent Identifierhttp://hdl.handle.net/10722/367717
ISSN
2023 Impact Factor: 5.3
2023 SCImago Journal Rankings: 2.249

 

DC FieldValueLanguage
dc.contributor.authorChan, Raymond C.K.-
dc.contributor.authorXu, Ting-
dc.contributor.authorHeinrichs, R. Walter-
dc.contributor.authorYu, Yue-
dc.contributor.authorWang, Ya-
dc.date.accessioned2025-12-19T07:58:50Z-
dc.date.available2025-12-19T07:58:50Z-
dc.date.issued2010-
dc.identifier.citationSchizophrenia Bulletin, 2010, v. 36, n. 6, p. 1089-1104-
dc.identifier.issn0586-7614-
dc.identifier.urihttp://hdl.handle.net/10722/367717-
dc.description.abstractBackground: Neurological soft signs (NSS) are hypothesized as candidate endophenotypes for schizophrenia, but their prevalence and relations with clinical and demographic data are unknown. The authors undertook a quantification (meta-analysis) of the published literature on NSS in patients with schizophrenia and healthy controls. A systematic search was conducted for published articles reporting NSS and related data using standard measures in schizophrenia and healthy comparison groups. Method: A systematic search was conducted for published articles reporting data on the prevalence of NSS in schizophrenia using standard clinical rating scales and healthy comparison groups. Meta-analyses were performed using the Comprehensive Meta-analysis software package. Effect sizes (Cohen d) indexing the difference between schizophrenic patients and the healthy controls were calculated on the basis of reported statistics. Potential moderator variables evaluated included age of patient samples, level of education, sample sex proportions, medication doses, and negative and positive symptoms. Results: A total of 33 articlesmet inclusion criteria for the meta-analysis. A large and reliable group difference (Cohen d) indicated that, on average, a majority of patients (73%) perform outside the range of healthy subjects on aggregate NSS measures. Cognitive performance and positive and negative symptoms share 2%-10%of their variance with NSS. Conclusions: NSS occur in a majority of the schizophrenia patient population and are largely distinct from symptomatic and cognitive features of the illness. © The Author 2009. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved.-
dc.languageeng-
dc.relation.ispartofSchizophrenia Bulletin-
dc.subjectMeta-analysis-
dc.subjectNeurological soft signs-
dc.subjectSchizophrenia-
dc.titleNeurological soft signs in schizophrenia: A meta-analysis-
dc.typeArticle-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1093/schbul/sbp011-
dc.identifier.pmid19377058-
dc.identifier.scopuseid_2-s2.0-78650098028-
dc.identifier.volume36-
dc.identifier.issue6-
dc.identifier.spage1089-
dc.identifier.epage1104-
dc.identifier.eissn1745-1701-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats